Embed Size (px)
Citation preview
© Renub Research Page 1 of 13
United States Anesthesia Drugs Market & Forecast
Renub Researchwww.renub.com
Published: December, 2014Copyright © 2014 Renub Research – All Rights Reserved
General Anesthesia Drugs
Methohexital Sodium…Pentobarbital
Fospropofol Disodium…Ketamine
Propofol…Benzodiazepines Class
Etomidate…Fentanyl
Local Anesthesia Drugs
Articane…Bupivacaine…Lidocaine
Mepivacaine…Prilocaine
© Renub Research Page 2 of 13
Anesthesia drugs are used during tests and surgical operations to induce sleep, which prevents
pain and discomfort and enables a wide range of medical procedures to be performed. Local
Anesthesia and General Anesthesia are the two commonly used types of anesthesia. Local
anesthesia is a condition when sensation within a specific body part in inhibited, where as
general anesthesia results in loss of consciousness and sensation.
United States anesthesia drugs market is expected to be more than US$ 3 Billion by 2018.
General Intravenous Anesthesia drugs market is dominating the United States anesthesia drugs
market. In further classification of General Intravenous Anesthesia Drugs market, Propofol
and Benzodiazepines Class (Diazepam and Midazolam) are the top contributors to intravenous
anesthetic drugs in the United States anesthesia drugs market. In classification of Local
Anesthesia Drugs Market Share Lidocaine holds the maximum market share. From companies
analysis part Baxter International Inc, Endo Health Solutions Inc and Abbott Laboratories
are three main players, but Others companies also play a major role in United States
anesthesia drugs market.
Renub Research report titled "United States Anesthesia Drugs Market & Forecast” provides
a comprehensive analysis of the current state of this market and likely future evolution over
the next 5 years. This 74 page report with 56 Figures and 1 Table provides a complete
analysis of local and general anesthesia drugs market in United States. This report has been
studied from 2 viewpoints.
1. General Anesthesia Drugs Market
2. Local Anesthesia Drugs Market
General Intravenous Anesthetic Drugs Market has been further divided into
1. Propofol
2. Benzodiazepines Class (Diazepam and Midazolam)
3. Fospropofol Disodium
4. Ketamine
5. Methohexital Sodium
6. Pentobarbital
7. Etomidate
© Renub Research Page 3 of 13
8. Fentanyl
United States Local Anesthetic Market has been further divided into
1. Articane
2. Bupivacaine
3. Lidocaine
4. Mepivacaine
5. Prilocaine
Key Players Profile in United States Anesthetic Drugs Market
1. Baxter International Inc
2. Endo Health Solutions Inc
3. Abbott Laboratories
4. AstraZeneca
Data Sources
This report is built using data and information sourced from proprietary databases, primary
and secondary research and in–house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephonic interviews with industry experts.
Secondary sources information and data has been collected from various printable and non–
printable sources like search engines, News websites, Government Websites, Trade Journals,
White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books,
Industry Portals, Industry Associations and access to more than 500 paid databases.
© Renub Research Page 4 of 13
About Us
RReennuubb RReesseeaarrcchh is a leading Market Research and Information Analysis Company with
centers at Noida India and Roswell USA. We have long–term experience especially in
international Business–to–Business Researches, Surveys, Business and Consulting. Throughout
the years we have acquired expertise in most market sectors, including Information
Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services
(Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG,
Consumer Goods, Logistics, Governmental, Social, and Others.
Our core team is comprised of an experienced people holding graduate, post graduate and
Ph.D. degrees in Finance, Marketing, Human Resource, Bio–Technology, Medicine, Information
Technology, Environmental Science and many more. Our research help make the business
decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We
support many blue chip companies by providing them findings and perspectives across a wide
range of markets. Our research reports offer a blend of information insight, analysis and
forecasting that is essential in today’s ultra–competitive markets.
For more information on us or to view any of our sample work you can
mail us at [email protected]
© Renub Research Page 5 of 13
Published
By
RReennuubb RReesseeaarrcchh
1st Floor,
C–86, Sector–10
Noida – 201301
Phone: +91–120–421–9822, 254–5750 (India)
+1–678–302–0700 (USA)
Fax : +91–120–424–9780
Email: [email protected]
www.renub.com
© United States Anesthesia Drugs Market & Forecast
Renub Research, 2014
Edition 1.0
All rights reserved. This publication is protected
by copyright. No part of it may be reproduced, stored
in a retrieval system or transmitted, in any form or by
any means, electronic mechanical, photocopying,
recording or otherwise without the prior written
permission of the publishers
© Renub Research Page 6 of 13
Table of Contents
1. Executive Summary
2. United States Anesthesia Drugs Market (2010 – 2018)
3. United States Anesthesia Drugs Market Share & Forecast (2010 – 2018)
3.1 United States Anesthesia Drugs Market Share & Forecast by Type (2010 – 2018)
3.2 United States General Intravenous Anesthesia Drugs Market Share & Forecast (2010 – 2018)
3.3 United States Local Anesthesia Drugs Market Share & Forecast (2010 – 2018)
3.4 United States Anesthesia Drugs Market Share & Forecast by Company (2010 – 2018)
4. By Type – United States Anesthesia Drugs Market (2008 – 2018)
4.1 United States General Inhalation Anesthesia Drugs Market (2008 – 2018)
4.2 United States General Intravenous Anesthesia Drugs Market (2008 – 2018)
4.3 United States Local Anesthesia Drugs Market (2008 – 2018)
5. By Drugs – United States General Intravenous Anesthesia Drugs Market (2010 – 2018)
5.1 United States Propofol Market (2010 – 2018)
5.2 United States Benzodiazepines Class (Diazepam and Midazolam) Market (2010 – 2018)
5.3 United States Fospropofol Disodium Market (2010 – 2018)
5.4 United States Ketamine Market (2010 – 2018)
5.5 United States Methohexital Sodium Market (2010 – 2018)
5.6 United States Pentobarbital Market (2010 – 2018)
5.7 United States Etomidate Market (2010 – 2018)
5.8 United States Fentanyl Market (2010 – 2018)
6. By Drugs – United States Local Anesthesia Drugs Market (2008 – 2018)
6.1 United States Articaine Market (2008 – 2018)
6.2 United States Bupivacaine Market (2008 – 2018)
6.3 United States Lidocaine Market (2008 – 2018)
6.4 United States Mepivacaine Market (2008 – 2018)
6.5 United States Prilocaine Market (2008 – 2018)
© Renub Research Page 7 of 13
7. Key Players Profile in United States Anesthesia Drugs Market
7.1 Baxter International Inc. Anesthesia Drugs Sales & Forecast (2008 – 2018)
7.2 Endo Health Solutions Inc. Anesthesia Drugs Sales & Forecast (2008 – 2018)
7.3 Abbott Laboratories Anesthesia Drugs Sales & Forecast (2008 – 2018)
7.4 AstraZeneca Anesthetic Drugs Sales (2009 – 2011)
8. United States Anesthesia Drugs Market – Growth Driver
8.1 Increasing Demand for Anesthesia Service
8.2 Increasing Ageing Population and Prevalence of Cardiovascular Disease in United States
8.2.1 Increasing Ageing Population
9. United States Anesthesia Drugs Market – Challenges
9.1 Shortage of Anesthesia Providers in United States
9.2 Shortage of Anesthesia Drugs in United States
© Renub Research Page 8 of 13
List of Figures:
Figure 2-1: United States – Anesthesia Drugs Market (Million US$), 2010 – 2013
Figure 2-2: United States – Forecast for Anesthesia Drugs Market (Million US$), 2014 – 2018
Figure 3-1: United States – Anesthesia Drugs Market Share by Type (Percent), 2010 – 2013
Figure 3-2: United States – Forecast for Anesthesia Drugs Market Share by Type (Percent), 2014 – 2018
Figure 3-3: United States – General Intravenous Anesthesia Drugs Market Share (Percent), 2010 – 2013
Figure 3-4: United States – Forecast for General Intravenous Anesthesia Drugs Market Share (Percent),
2014 – 2018
Figure 3-5: United States – Local Anesthesia Drugs Market Share (Percent), 2010 – 2013
Figure 3-6: United States – Forecast for Local Anesthesia Drugs Market Share (Percent), 2014 – 2018
Figure 3-7: United States – Anesthesia Drugs Market Share by Company (Percent), 2010 – 2013
Figure 3-8: United States – Forecast for Anesthesia Drugs Market Share by Company (Percent), 2014 –
2018
Figure 4-1: United States – General Inhalation Anesthesia Drugs Market (Million US$), 2008 – 2013
Figure 4-2: United States – Forecast for General Inhalation Anesthesia Drugs Market (Million US$), 2014
– 2018
Figure 4-3: United States – General Intravenous Anesthesia Drugs Market (Million US$), 2008 – 2013
Figure 4-4: United States – Forecast for General Intravenous Anesthesia Drugs Market (Million US$),
2014 – 2018
Figure 4-5: United States – Local Anesthesia Drugs Market (Million US$), 2008 – 2013
Figure 4-6: United States – Forecast for Local Anesthesia Drugs Market (Million US$), 2014 – 2018
Figure 5-1: United States – Propofol Market (Million US$), 2010 – 2013
Figure 5-2: United States – Forecast for Propofol Market (Million US$), 2014 – 2018
Figure 5-3: United States – Benzodiazepines Class Market (Million US$), 2010 – 2013
Figure 5-4: United States – Forecast for Benzodiazepines Class Market (Million US$), 2014 – 2018
Figure 5-5: United States – Fospropofol Disodium Market (Million US$), 2010 – 2013
Figure 5-6: United States – Forecast for Fospropofol Disodium Market (Million US$), 2014 – 2018
Figure 5-7: United States – Ketamine Market (Million US$), 2010 – 2013
Figure 5-8: United States – Forecast for Ketamine Market (Million US$), 2014 – 2018
Figure 5-9: United States – Methohexital Sodium Market (Million US$), 2010 – 2013
Figure 5-10: United States – Forecast for Methohexital Sodium Market (Million US$), 2014 – 2018
Figure 5-11: United States – Pentobarbital Market (Million US$), 2010 – 2013
Figure 5-12: United States – Forecast for Pentobarbital Market (Million US$), 2014 – 2018
Figure 5-13: United States – Etomidate Market (Million US$), 2010 – 2013
Figure 5-14: United States – Forecast for Etomidate Market (Million US$), 2014 – 2018
Figure 5-15: United States – Fentanyl Market (Million US$), 2010 – 2013
© Renub Research Page 9 of 13
Figure 5-16: United States – Forecast for Fentanyl Market (Million US$), 2014 – 2018
Figure 6-1: United States – Articaine Market (Million US$), 2008 – 2013
Figure 6-2: United States – Forecast for Articane Market (Million US$), 2014 – 2018
Figure 6-3: United States – Bupivacaine Market (Million US$), 2008 – 2013
Figure 6-4: United States – Forecast for Bupivacaine Market (Million US$), 2014 – 2018
Figure 6-5: United States – Lidocaine Market (Million US$), 2008 – 2013
Figure 6-6: United States – Forecast for Lidocaine Market (Million US$), 2014 – 2018
Figure 6-7: United States – Mepivacaine Market (Million US$), 2008 – 2013
Figure 6-8: United States – Forecast for Mepivacaine Market (Million US$), 2014 – 2018
Figure 6-9: United States – Prilocaine Market (Million US$), 2008 – 2013
Figure 6-10: United States – Forecast for Prilocaine Market (Million US$), 2014 – 2018
Figure 7-1: United States – Baxter International Anesthesia Drugs Sales (Million US$), 2008 – 2013
Figure 7-2: United States – Forecast for Baxter International Anesthesia Drugs Sales (Million US$), 2014
– 2018
Figure 7-3: United States – Endo Health Solutions Anesthesia Drugs Sales (Million US$), 2008 – 2013
Figure 7-4: United States – Forecast for Endo Health Solutions Anesthesia Drugs Sales (Million US$),
2014 – 2018
Figure 7-5: United States – Abbott Laboratories Anesthesia Drugs Sales (Million US$), 2008 – 2013
Figure 7-6: United States – Forecast for Abbott Laboratories Anesthesia Drugs Sales (Million US$), 2014
– 2018
Figure 7-7: United States – AstraZeneca Anesthesia Drugs Sales (Million US$), 2009 – 2011
Figure 8-1: United States – Cosmetic Procedures (Number), 1997, 2012, 2013
Figure 8-2: United States – Number of Surgical Procedure (Thousand), 2007 – 2010
Figure 8-3: United States – Ageing Population by Age Group (Thousand), 2009 – 2012
Figure 9-1: United States – By Region Availability of Anesthesia Specialists (Percent), 2010
Figure 9-2: United States – By States Availability of Anesthesia Specialists (Percent), 2010
Figure 9-3: United States – Drugs Shortage (Number), 2006, 2011, 2012
Figure 9-4: United States – Anesthesia Drugs Shortage with the Highest Frequency (Percent), 2012
© Renub Research Page 10 of 13
List of Tables:
Table 8–1: United States – Cardiovascular Disease Prevalence (Percent), 2010,2015,2020,2025, 2030
© Renub Research Page 11 of 13
Order Form
Scan and e-mail this page to [email protected], alternatively one can also write the Contact
Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780
Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to
Format
Report Title: United States Anesthesia Drugs Market & Forecast
Single User (Email from Publisher)
Hard Copy (Mail Delivery)
CD – Rom (Mail Delivery)
Global Site License (Multiple User License)
US$ 1,450 US$ 1,550 US$ 1,550 US$ 2,100
For ordering this report: Three easy ways to place your order:
1) Order online by Credit Card (Visa, MasterCard, etc.):
http://www.renub.com/report/united-states-anesthesia-drugs-market-forecast-155
2) Order by Wire Transfer:
http://www.renub.com/report/wiretransfer.aspx?id=155&pid=1593
To pay by Wire Transfer, please, fill in your contact details in the form below:
© Renub Research Page 12 of 13
Bank Details
Account Name: Renub Research
A/C No.: 109102000023296
Name of Bank: IDBI Bank Ltd.
Swift Code: IBKLINBB010
Bank Address: 4th Floor
Indian Red Cross Building
1 Red Cross Road
Opposite Parliament Street
New Delhi – 110001
India
Contact Information
First Name: Last Name:
Email:
Job Title:
Company:
Address:
City:
Postal/Zip Code:
Country:
Phone:
Mobile:
Fax:
Report Format:
Your message:
© Renub Research Page 13 of 13
3) Order by Check
Please post the check accompanied by this form, to:
Company Address: Renub Research
1st Floor
C-86, Sector -10
Noida - 201301
Uttar Pradesh
India
Phone: +91-120-421-9822, 424-9780
For free Sample copy report or to view any of our sample work please contact us at
[email protected] or call +91-120-421-9822 (India), +1-678-302-0700 (USA)
Follow Us
Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090
LinkedIn: http://www.linkedin.com/company/renub-research
Twitter: http://twitter.com/RenubResearch
